STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[Form 4] Crocs, Inc. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Positive)
Form Type
4
Rhea-AI Filing Summary

John B. Replogle, a director of Crocs, Inc. (CROX), reported purchases of company stock on 08/08/2025. He acquired 336 shares at a weighted-average price of $76.302 and 2,925 shares at a weighted-average price of $76.734, for a total of 3,261 shares added to his holdings. The filings show beneficial ownership of 12,492 shares after the first reported purchase and 15,417 shares following the second reported purchase.

The report discloses that the purchases were executed in multiple transactions with price ranges of $75.550 to $76.426 and $76.595 to $76.750 for the two groups of shares, respectively, and the filer's footnotes offer to provide a breakdown of shares purchased at each price upon request.

Positive
  • Director John B. Replogle purchased a total of 3,261 CROX shares, increasing reported beneficial ownership to 15,417 shares.
Negative
  • None.

Insights

Director bought 3,261 CROX shares at ~ $76, modestly increasing direct ownership to 15,417 shares.

The transactions on 08/08/2025 consist of two non-derivative purchases: 336 shares at a weighted-average of $76.302 and 2,925 shares at a weighted-average of $76.734. The filing reports direct beneficial ownership rising from 12,492 to 15,417 shares. The disclosure includes the weighted-average price ranges for the underlying executions, which improves transparency about trade execution. For a public company of Crocs' size these purchases are notable as insider buy activity but are not transformational on their own.

Form 4 properly discloses director purchases and direct beneficial ownership increases with price ranges and weighted averages.

The Form 4 shows the reporting person is a director and that the ownership form is direct (D) for both transactions. Footnotes explicitly state weighted-average prices and the ranges of execution prices, and the filer offers to provide a per-price breakdown if requested, which supports disclosure completeness. The report is routine in form and provides the required specificity for Section 16 reporting.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
REPLOGLE JOHN B

(Last) (First) (Middle)
C/O CROCS, INC.
500 ELDORADO BLVD #5

(Street)
BROOMFIELD CO 80021

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Crocs, Inc. [ CROX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/08/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/08/2025 P 336 A $76.302(1) 12,492 D
Common Stock 08/08/2025 P 2,925 A $76.734(2) 15,417 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $75.550 to $76.426, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes 1 and 2.
2. The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging $76.595 to $76.750, inclusive.
Remarks:
/s/Sara Hoverstock, Attorney-in-Fact 08/13/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did John B. Replogle report on Form 4 for CROX?

The Form 4 reports two non-derivative purchases on 08/08/2025: 336 shares at a weighted-average price of $76.302 and 2,925 shares at a weighted-average price of $76.734.

How many CROX shares does the reporting person beneficially own after these transactions?

The filing shows beneficial ownership of 12,492 shares after the first reported purchase and 15,417 shares after the second reported purchase.

Were the purchases executed at single prices or multiple prices?

The filing states the shares were purchased in multiple transactions. Footnotes give execution price ranges: $75.550 to $76.426 for the first group and $76.595 to $76.750 for the second group, with weighted-average prices reported.

Is the ownership shown as direct or indirect in the Form 4?

The transactions are reported with the ownership form marked as Direct (D) for both purchases.

Does the Form 4 offer additional breakdowns of executed prices?

Yes. Footnotes state the reporting person will provide, upon request, full information regarding the number of shares purchased at each separate price within the disclosed ranges.
Crocs Inc

NASDAQ:CROX

CROX Rankings

CROX Latest News

CROX Latest SEC Filings

CROX Stock Data

4.08B
50.03M
3.28%
103.97%
11.75%
Footwear & Accessories
Rubber & Plastics Footwear
Link
United States
BROOMFIELD